GNMT overexpression alleviates renal inflammation and fibrosis, presenting a new therapeutic target for DKD.328 Although GNMT is considered a novel therapeutic target for DKD, treatment strategies targeting GNMT may need to account for individual differences, such as genetic polymorphisms, disease stage, and comorbidities, all of which could influence treatment outcomes. This evidence concerns the gene GNMT and diabetic kidney disease.